Literature DB >> 17186373

Does Abeta 42 have a function related to blood homeostasis?

John Hardy1.   

Abstract

In this review, I discuss the possibility that Abeta42 has a physiologic function in blood vessel homeostasis and the consequences that this might have for theories concerning the pathogenesis of Alzheimer's disease and for treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186373     DOI: 10.1007/s11064-006-9221-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

Review 1.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

Review 2.  Regulation of CRE-dependent transcription by presenilins: prospects for therapy of Alzheimer's disease.

Authors:  Vassilios Beglopoulos; Jie Shen
Journal:  Trends Pharmacol Sci       Date:  2005-12-07       Impact factor: 14.819

3.  APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.

Authors:  Anne Rovelet-Lecrux; Didier Hannequin; Gregory Raux; Nathalie Le Meur; Annie Laquerrière; Anne Vital; Cécile Dumanchin; Sébastien Feuillette; Alexis Brice; Martine Vercelletto; Frédéric Dubas; Thierry Frebourg; Dominique Campion
Journal:  Nat Genet       Date:  2005-12-20       Impact factor: 38.330

4.  Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.

Authors:  Samir Kumar-Singh; Daniel Pirici; Eileen McGowan; Sally Serneels; Chantal Ceuterick; John Hardy; Karen Duff; Dennis Dickson; Christine Van Broeckhoven
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

5.  Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein.

Authors:  W E Van Nostrand; A H Schmaier; J S Farrow; D D Cunningham
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

Review 6.  An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease.

Authors:  J A Hardy; D M Mann; P Wester; B Winblad
Journal:  Neurobiol Aging       Date:  1986 Nov-Dec       Impact factor: 4.673

7.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

Review 8.  Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.

Authors:  M O McCarron; J A Nicoll
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 9.  Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply.

Authors:  Craig S Atwood; Richard L Bowen; Mark A Smith; George Perry
Journal:  Brain Res Brain Res Rev       Date:  2003-09

Review 10.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

View more
  10 in total

Review 1.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

2.  The characteristics of astrocyte on Aβ clearance altered in Alzheimer's disease were reversed by anti-inflammatory agent (+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate.

Authors:  Sanjaya Kuruppu; Niwanthi W Rajapakse; Helena C Parkington; A Ian Smith
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

3.  Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Justin Paul; Erin H Norris; Robert Bronstein; Hyung Jin Ahn; Daria Zamolodchikov; Shivaprasad Bhuvanendran; Katherine M Fenz; Sidney Strickland
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

4.  Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis.

Authors:  Jennifer Webster; Eric M Reiman; Victoria L Zismann; Keta D Joshipura; John V Pearson; Diane Hu-Lince; Matthew J Huentelman; David W Craig; Keith D Coon; Thomas Beach; Kristen C Rohrer; Alice S Zhao; Doris Leung; Leslie Bryden; Lauren Marlowe; Mona Kaleem; Diego Mastroeni; Andrew Grover; Joseph Rogers; Reinhard Heun; Frank Jessen; Heike Kölsch; Christopher B Heward; Rivka Ravid; Michael L Hutton; Stacey Melquist; Ron C Petersen; Richard J Caselli; Andreas Papassotiropoulos; Dietrich A Stephan; John Hardy; Amanda Myers
Journal:  Int J Mol Epidemiol Genet       Date:  2009-07-26

Review 5.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

Review 6.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

7.  The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?

Authors:  N N Nalivaeva; N D Belyaev; I A Zhuravin; A J Turner
Journal:  Int J Alzheimers Dis       Date:  2012-07-26

8.  Neprilysin Inhibits Coagulation through Proteolytic Inactivation of Fibrinogen.

Authors:  Matthew Burrell; Simon J Henderson; Anna Ravnefjord; Fritz Schweikart; Susan B Fowler; Susanne Witt; Kenny M Hansson; Carl I Webster
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

9.  Blood platelets in the progression of Alzheimer's disease.

Authors:  Nina S Gowert; Lili Donner; Madhumita Chatterjee; Yvonne S Eisele; Seyda T Towhid; Patrick Münzer; Britta Walker; Isabella Ogorek; Oliver Borst; Maria Grandoch; Martin Schaller; Jens W Fischer; Meinrad Gawaz; Sascha Weggen; Florian Lang; Mathias Jucker; Margitta Elvers
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Platelets isolated from an Alzheimer mouse damage healthy cortical vessels and cause inflammation in an organotypic ex vivo brain slice model.

Authors:  Kathrin M Kniewallner; Bettina M Foidl; Christian Humpel
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.